Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022 | The Motley Fool

Retrieved on: 2021-11-27 17:09:06

Tags for this article:

Articles

Life Sciences

Health sciences

Medical research

AstraZeneca

Oxford–AstraZeneca COVID-19 vaccine

COVID-19 vaccine

Moderna

Alexion Pharmaceuticals

European Commission–AstraZeneca COVID-19 vaccine dispute

COVID-19 vaccination in Vietnam

S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022 | The Motley Fool. View article details on HISWAI: https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/

Excerpt

Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's ...

Article found on: www.fool.com

View Original Article